Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Optimize and Validate the Treatment Parameters for the Empower Neuromodulation System

NCT03807544 is registered in ClinicalTrials.gov with Theranova, L.L.C. as lead sponsor.

NCT NCT03807544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03807544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Optimize and Validate the Treatment Parameters for the Empower Neuromodulation System
Lead sponsor
Theranova, L.L.C.
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2019
Completion date
March 13, 2019
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder